Jeff Garro
Stock Analyst at Stephens & Co.
(1.14)
# 3,752
Out of 4,996 analysts
54
Total ratings
35.14%
Success rate
-11.17%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.98 | +33.44% | 5 | Sep 24, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $8.95 | +0.56% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $23.62 | +35.48% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $14.89 | +34.32% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.48 | +36.72% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $290.27 | -3.54% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.80 | +78.57% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.80 | +44.07% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.98 | +25.63% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $74.40 | -26.08% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $5.5 | $18.78 | -70.71% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $179.56 | +39.23% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.14 | -11.18% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.16 | +243.14% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $17.53 | +14.09% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $4.79 | -18.58% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.03 | +47.78% | 3 | May 6, 2022 |
Privia Health Group
Sep 24, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.98
Upside: +33.44%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $8.95
Upside: +0.56%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.62
Upside: +35.48%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $14.89
Upside: +34.32%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.48
Upside: +36.72%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $290.27
Upside: -3.54%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.80
Upside: +78.57%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.80
Upside: +44.07%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.98
Upside: +25.63%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $74.40
Upside: -26.08%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $18.78
Upside: -70.71%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $179.56
Upside: +39.23%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.14
Upside: -11.18%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.16
Upside: +243.14%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $17.53
Upside: +14.09%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $4.79
Upside: -18.58%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.03
Upside: +47.78%